[ 1 ] Haupt R, Minkov M, Astigarraga I, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years[J]. Pediatr Blood Cancer, 2013, 60(2): 175-184.
[2]
[ 2 ] Suri HS, Yi ES, Nowakowski GS, et al. Pulmonary langerhans cell histiocytosis[J]. Orphanet J Rare Dis, 2012, 7(1): 1-13.
[3]
[ 3 ] Braier J, Latella A, Balancini B, et al. Outcome in children with pulmonary Langerhans cell Histiocytosis[J]. Pediatr Blood Cancer, 2004, 43(7): 765-769.
[4]
[ 4 ] Morimoto A, Ikushima S, Kinugawa N, et al. Improved outcome in the treatment of pediatric multifocal langerhans cell histiocytosis：results from the japan langerhans cell histiocytosis study group-96 protocol study[J]. Cancer , 2006, 107(3): 613-619.
[5]
[ 5 ] Nanduri VR, Pritchard J, Levitt G, et al. Long term morbidity and health related quality of Life after multi-system Langerhans cell histiocytosis[J]. Eur J Cancer, 2006, 42(15): 2563-2569.
[6]
[ 6 ] Ciuche A, Nistor C, Pantile D, et al. Spontaneous pneumothorax in a case of pulmonary langerhans cell histiocytosis[J]. Maedica (Buchar), 2011, 6(3): 204-209.
[7]
[ 7 ] Kim HJ, Lee KS, Johkoh T, et al. Pulmonary langerhans cell histiocytosis in adults: high-resolution CT-pathology comparisons and evolutional changes at CT[J]. Eur Radiol, 2011, 21(7): 1406-1415.
[8]
[ 8 ] Seely JM, Salahudeen S Sr, Cadaval-Goncalves AT, et al. Pulmonary langerhans cell histiocytosis: a comparative study of computed tomography in children and adults[J]. J Thorac Imaging, 2012, 27(1): 65-70.
[9]
[ 9 ] Weitzman S, Braier J, DonadieuJ, et al. 2’-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society[J]. Pediatr Blood Cancer, 2009, 53(7): 1271-1276.
